Table S5 from Statin-induced Mitochondrial Priming Sensitizes Multiple Myeloma Cells to BCL2 and MCL-1 Inhibitors

作者：Dennis Juarez, Roberta Buono, Shannon M. Matulis, Vikas A. Gupta, Madeleine Duong, Jacob Yudiono, Madhuri Paul, Sharmila Mallya, Grace Diep, Peter Hsin, Alexander Lu, Sang Mi Suh, Vy M. Dong, Andrew W. Roberts, Joel D. Leverson, Muhammad Jalaluddin, Zhuangzhuang Liu, Orlando F. Bueno, Lawrence Boise, David A. Fruman · 年份：2023 · DOI：10.1158/2767-9764.24772979 · 研究领域：Multiple Myeloma Research and Treatments、Protein Degradation and Inhibitors、Computational Drug Discovery Methods

<p>Supplementary Table S5 presents multivariate analysis of pooled clinical trial data on R/R MM patients achieving complete response (CR) or better – variables include statin use, t11;14 status, prior lines of therapy, cytogenetic risk.</p>